All In MedTech

Device Trial Radar · NCT02373852

PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention

Post Marketing Surveillance (PMS) Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention

Last checked: Nov 21, 2026Latest source record: Sep 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

12

Actual

Start

Oct 2014

Primary completion

May 2015

Study completion Jun 2016

Sponsor

Lead sponsor
Gardia MedicalNot on our public-company list
Sponsor type
Industry
First posted
Feb 27, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to collect data on the use of the WIRION system in Patients undergoing Percutaneous Intervention of Saphenous Vein Graft (SVG).

Conditions

  • Stenosis

Interventions

  • Saphenous vein graft (SVG) stentingDevice

    Opening and stenting of blocked SVG with the use of the WIRION embolic protection filter

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adverse Events During the Procedure and up to 30 Days Following ProcedureTime frame: 30 Days

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bnai Zion

    Haifa, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.